• Angiotensin Peptides Modulate SARS-CoV-2 Spike–Receptor Inte

  2026-07-16

  This study reveals that naturally occurring angiotensin peptides, including variants derived from Angiotensin I, can enhance the binding of the SARS-CoV-2 spike protein to cellular receptors—particularly AXL—implicating a novel molecular link between the renin-angiotensin system and COVID-19 pathogenesis. These findings highlight the importance of peptide structure and sequence in modulating viral entry, opening new avenues for mechanistic research and therapeutic targeting.

• Berberine Hydrochloride in Gut–Bone Axis & Osteometabolic Re

  2026-07-16

  Berberine hydrochloride enables cutting-edge workflows in metabolic and bone loss research by uniquely expanding intestinal tuft cells and modulating gut–bone signaling. This article translates recent mechanistic breakthroughs into practical, stepwise protocols and troubleshooting tips, positioning APExBIO’s high-purity compound as a linchpin for translational studies in osteoimmunology and beyond.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): Pro

  2026-07-15

  DIDS, a benchmark anion transport inhibitor from APExBIO, unlocks advanced manipulation of chloride and TRPV1 channels in cancer, neuroprotection, and vascular research. This guide translates recent breakthroughs into actionable protocols, troubleshooting strategies, and workflow optimizations for maximizing DIDS's translational impact.

• Dovitinib (TKI-258): Mechanistic Power and Translational Pro

  2026-07-15

  This thought-leadership article explores the mechanistic depth and translational opportunity of Dovitinib (TKI-258, CHIR-258) as a multitargeted receptor tyrosine kinase inhibitor in advanced oncology research. We dissect its impact on ERK and STAT signaling, integrate new insights from immune-oncology, and deliver actionable guidance for leveraging Dovitinib in translational workflows—highlighting strategic differentiation beyond standard product content.

• EZ Cap™ Human PTEN mRNA: Precision Engineering for Tumor Sup

  2026-07-14

  Explore how EZ Cap™ Human PTEN mRNA empowers cancer research and gene therapy through advanced capping, stability, and translational efficiency. This article uniquely dissects the product’s molecular design and practical assay implications, setting it apart in tumor suppressor gene mRNA applications.

• Ruthenium Red as a Ca2+ Transport Inhibitor in Cytoskeleton-

  2026-07-14

  Ruthenium Red empowers calcium signaling research by enabling precise inhibition of Ca2+ transport across key cellular membranes, making it indispensable for dissecting cytoskeleton-dependent autophagy and mechanotransduction. This guide delivers actionable workflows, troubleshooting insights, and cross-study protocol enhancements for advanced experimental design.

• PXR Activation Drives Liver Growth and CYP Induction in Rats

  2026-07-13

  This study demonstrates that pregnane X receptor (PXR) activation in rats not only induces liver enlargement and regeneration but also upregulates the expression and metabolic activity of key cytochrome P450 enzymes, CYP3A1/2 and CYP2C6/11. These findings clarify the coordinated role of PXR in hepatic adaptation and drug metabolism, informing both liver disease modeling and pharmacokinetic research.

• Cytoskeletal Control of Mechanical Stress-Induced Autophagy

  2026-07-13

  This study demonstrates that the induction of autophagy by mechanical stress in human cells is critically dependent on the cytoskeleton, particularly on microfilaments. By systematically modulating cytoskeletal components, the authors clarify the mechanotransduction pathways linking force sensing to autophagic responses, advancing both conceptual understanding and experimental approaches for calcium signaling research.

• Urolithin A: Advancing Mitochondrial Quality and Fibrosis Re

  2026-07-12

  Explore how Urolithin A, a potent mitophagy activator, is revolutionizing mitochondrial biogenesis research and offering new perspectives for metabolic and fibrosis studies. This in-depth analysis highlights mechanisms, protocol insights, and practical applications.

• BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma RGC Models

  2026-07-10

  The referenced study demonstrates that BMP4-driven GPX4 upregulation protects retinal ganglion cells (RGCs) from ferroptosis in a mouse glaucoma model, while enhancing the differentiation of transplanted retinal stem cells. These findings highlight a mechanistic pathway with translational potential for neuroprotection and stem cell therapy in high intraocular pressure glaucoma.

• Bazedoxifene (SKU A3232): Reliable SERM for Lab Assays

  2026-07-09

  This article guides biomedical researchers and lab technicians through the practical use of Bazedoxifene (SKU A3232) in cell-based assays, emphasizing data-backed workflow improvements in estrogen receptor signaling, bone mineral density studies, and more. Each scenario illustrates how choosing Bazedoxifene from a trusted supplier like APExBIO ensures reproducibility and scientific rigor.

• Capsaicin in Precision Research: TRPV1 & KDM1A Workflow Opti

  2026-07-09

  Capsaicin ((E)-Capsaicin) is redefining experimental design as a dual-action tool for TRPV1 ion channel activation and reversible KDM1A/LSD1 inhibition. This article translates cutting-edge findings into actionable protocols, troubleshooting strategies, and comparative insights for researchers targeting pain, inflammation, and cancer.

• Resiniferatoxin (RTX): Optimizing TRPV1 Desensitization Work

  2026-07-08

  Resiniferatoxin (RTX) delivers unmatched TRPV1 selectivity and potency, enabling durable sensory neuron desensitization for advanced pain and inflammation models. Discover stepwise protocols, troubleshooting tactics, and novel applications that set RTX apart from traditional TRPV1 modulators.

• Capsazepine: TRPV1 Ion Channel Antagonist in Pain Research

  2026-07-08

  Capsazepine, a potent TRPV1 antagonist, enables precise dissection of pain and apoptosis mechanisms in experimental models. This guide delivers actionable protocols, troubleshooting advice, and insights drawn from the latest research—including the multidimensional framework provided by cutting-edge cannabidiol pain studies.

• RNA Pol II Inhibition Triggers Apoptosis Independent of Tran

  2026-07-07

  Harper et al. (2025) demonstrate that the loss of hypophosphorylated RNA Pol IIA, rather than transcriptional shutdown, initiates a regulated apoptotic program in eukaryotic cells. This mechanistic insight reframes how cell death is triggered by transcriptional inhibitors, with implications for apoptosis-targeted cancer research.

14760 records 1/984 page Next 12345 下5页 Last page